Skip to main navigation Skip to search Skip to main content

Type II diabetes mellitus and menopause: A multinational study

  • A. Monterrosa-Castro
  • , J. E. Blümel
  • , K. Portela-Buelvas
  • , E. Mezones-Holguín
  • , G. Barón
  • , A. Bencosme
  • , Z. Benítez
  • , L. M. Bravo
  • , A. Calle
  • , P. Chedraui
  • , D. Flores
  • , M. T. Espinoza
  • , G. Gómez
  • , J. A. Hernández-Bueno
  • , F. Laribezcoa
  • , S. Lima
  • , M. Martino
  • , D. Mostajo
  • , E. Ojeda
  • , W. Onatra
  • H. Sánchez, D. Navarro, K. Tserotas, M. S. Vallejo, S. Witis, M. C. Zuñiga
  • Universidad de Cartagena
  • Universidad de Chile
  • Centro Nacional de Salud Pública
  • Universidad El Bosque
  • Hospital Metropolitano
  • Hospital Central
  • Universidad de Guadalajara
  • Universidad Central del Ecuador
  • Universidad Católica de Santiago de Guayaquil
  • Universidad Diego Portales
  • Caja de Salud de la Banca Privada
  • Universidad del Valle
  • Atención Médica Integral para la Mujer
  • Universidad Nacional de Piura
  • Hospital Militar
  • Universidad Nacional de Rosario
  • Unidad de Diagnóstico Médico
  • Universidad Andina del Cusco
  • Universidad de Ciencias Aplicadas y Ambientales
  • Hospital de SOLCA
  • Instituto Nacional de Endocrinología
  • University of Panama
  • Universidad de Buenos Aires
  • Obra Social de Empleado Públicos

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Background Type II diabetes mellitus causes metabolic changes that may lead to early menopause and worsen climacteric symptoms. Objectives To determine the risk factors for type II diabetes mellitus and assess the impact of this disease on the age of menopause and on climacteric symptoms. Methods A total of 6079 women aged between 40 and 59 years from 11 Latin American countries were requested to answer the Menopause Rating Scale and Goldberg Anxiety-Depression Scale. Results The prevalence of diabetes was 6.7%. Diabetes mellitus was associated with arterial hypertension (odds ratio (OR) 4.49; 95% confidence interval (CI) 3.47-5.31), the use of psychotropic drugs (OR 1.54; 95% CI 1.22-1.94), hormonal therapy (OR 1.46; 95% CI 1.11-1.92), ≥ 50 years of age (OR 1.48; 95% CI 1.17-1.86), overweight or obese (OR 1.47; 95% CI 1.15-1.89), and waist circumference ≥ 88 cm (OR 1.32; 95% CI 1.06-1.65). Factors associated with lower risk of diabetes were the use of hormonal contraceptives (OR 0.55; 95% CI 0.35-0.87), alcohol (OR 0.73; 95% CI 0.54-0.98) and living in cities > 2500 meters above sea level (OR 0.70; 95% CI 0.53-0.91) or with high temperatures (OR 0.67; 95% CI 0.51-0.88). In turn, diabetes tripled the risk of menopause in women under 45 years of age. Diabetes did not increase the risk of deterioration of quality of life due to climacteric symptoms. Conclusion Menopause does not increase the risk of type II diabetes mellitus. Diabetes is associated with early menopause in women under 45 years of age.

Original languageEnglish
Pages (from-to)663-672
Number of pages10
JournalClimacteric
Volume16
Issue number6
DOIs
StatePublished - Dec 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Blood Pressure
  • Climacteric Symptoms
  • Latin America
  • Menopause
  • Type II Diabetes

Fingerprint

Dive into the research topics of 'Type II diabetes mellitus and menopause: A multinational study'. Together they form a unique fingerprint.

Cite this